Form 13F-HR Cormorant Asset Manageme For: Mar 31

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2022

1. AMZN
2. SPY
3. VERU
4. CRM
5. AAPL
6. RIVN
7. AMTI
8. KRNT


May 16, 2022 3:07 PM EDT
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
Report for the Calendar Year or Quarter Ended: 03-31-2022
Check here if Amendment   Amendment Number:
This Amendment (Check only one.):   is a restatement.
  adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Cormorant Asset Management, LP
Address: 200 CLARENDON STREET
52ND FLOOR
BOSTON , MA02116
Form 13F File Number: 028-15949

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name: Neb Obradovic
Title: GC/CCO
Phone: 857-702-0370
Signature, Place, and Date of Signing:
/s/ Neb Obradovic Boston , MA 05-16-2022
[Signature] [City, State] [Date]
Report Type (Check only one.):
X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
  13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
  13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)
Form 13F Summary Page
Report Summary:
Number of Other Included Managers: 1
Form 13F Information Table Entry Total: 77
Form 13F Information Table Value Total: 1,302,462
(thousands)
List of Other Managers Reporting for this Manager:
[If there are no entries in this list, omit this section.]
Form 13F File Number Name
028-15950 Chen Bihua

List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state “NONE” and omit the column headings and list entries.]
No. Form 13F File Number Name
1 028-15950 Chen Bihua

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADICET BIO INC COM 007002108 14,978 750,000 SH DFND 1 750,000 0 0
AEROVATE THERAPEUTICS INC COM 008064107 33,557 1,830,691 SH DFND 1 1,830,691 0 0
AKERO THERAPEUTICS INC COM 00973Y108 5,730 403,787 SH DFND 1 403,787 0 0
AKOUOS INC COM 00973J101 1,874 394,500 SH DFND 1 394,500 0 0
ALX ONCOLOGY HLDGS INC COM 00166B105 12,034 712,079 SH DFND 1 712,079 0 0
AMBRX BIOPHARMA INC SPONSORED ADS 02290A102 10,244 2,486,386 SH DFND 1 2,486,386 0 0
ANAPTYSBIO INC COM 032724106 1,237 50,000 SH DFND 1 50,000 0 0
APELLIS PHARMACEUTICALS INC COM 03753U106 57,161 1,125,000 SH DFND 1 1,125,000 0 0
ASCENDIS PHARMA A/S SPONSORED ADR 04351P101 5,868 50,000 SH DFND 1 50,000 0 0
ASTRIA THERAPEUTICS INC COM 04635X102 2,013 300,000 SH DFND 1 300,000 0 0
ATEA PHARMACEUTICALS INC COM 04683R106 11,171 1,547,181 SH DFND 1 1,547,181 0 0
ATRECA INC CL A COM 04965G109 2,536 800,000 SH DFND 1 800,000 0 0
AUTOLUS THERAPEUTICS PLC SPON ADS 05280R100 1,635 392,167 SH DFND 1 392,167 0 0
AVIDITY BIOSCIENCES INC COM 05370A108 37,164 2,012,115 SH DFND 1 2,012,115 0 0
AXONICS INC COM 05465P101 20,172 322,240 SH DFND 1 322,240 0 0
BEAM THERAPEUTICS INC COM 07373V105 5,160 90,045 SH DFND 1 90,045 0 0
BIOATLA INC COM 09077B104 10,191 2,038,215 SH DFND 1 2,038,215 0 0
BIOHAVEN PHARMACTL HLDG CO L COM G11196105 9,486 80,000 SH DFND 1 80,000 0 0
BIOMEA FUSION INC COM 09077A106 14,142 3,170,872 SH DFND 1 3,170,872 0 0
BRIDGEBIO PHARMA INC COM 10806X102 15,924 1,568,909 SH DFND 1 1,568,909 0 0
CABALETTA BIO INC COM 12674W109 2,343 1,154,424 SH DFND 1 1,154,424 0 0
CENTESSA PHARMACEUTICALS PLC SPONSORED ADS 152309100 22,334 2,489,894 SH DFND 1 2,489,894 0 0
CHEMOCENTRYX INC COM 16383L106 21,686 865,000 SH DFND 1 865,000 0 0
CHEMOMAB THERAPEUTICS LTD SPONSORED ADS 16385C104 1,383 288,168 SH DFND 1 288,168 0 0
CYTOKINETICS INC COM NEW 23282W605 14,724 400,000 SH DFND 1 400,000 0 0
DESIGN THERAPEUTICS INC COM 25056L103 83,285 5,156,994 SH DFND 1 5,156,994 0 0
EDGEWISE THERAPEUTICS INC COM 28036F105 45,424 4,682,874 SH DFND 1 4,682,874 0 0
ELEDON PHARMACEUTICALS INC COM 28617K101 5,142 1,305,095 SH DFND 1 1,305,095 0 0
ELEVATION ONCOLOGY INC COM 28623U101 4,998 1,983,165 SH DFND 1 1,983,165 0 0
ERASCA INC COM 29479A108 90,348 10,505,554 SH DFND 1 10,505,554 0 0
FORMA THERAPEUTICS HLDGS INC SHS 34633R104 37,836 4,068,351 SH DFND 1 4,068,351 0 0
GALECTO INC COM 36322Q107 2,245 1,020,238 SH DFND 1 1,020,238 0 0
GELESIS HLDGS INC COM 36850R204 2,751 626,108 SH DFND 1 626,108 0 0
GH RESEARCH PLC ORDINARY SHARES G3855L106 11,123 608,123 SH DFND 1 608,123 0 0
GOSSAMER BIO INC COM 38341P102 1,722 198,382 SH DFND 1 198,382 0 0
GRAPHITE BIO INC COM 38870X104 1,036 203,153 SH DFND 1 203,153 0 0
GREENLIGHT BIOSCIENCS HLDS P COMMON STOCK 39536G105 62,038 6,710,540 SH DFND 1 6,710,540 0 0
HARPOON THERAPEUTICS INC COM 41358P106 2,687 540,600 SH DFND 1 540,600 0 0
HELIX ACQUISITION CORP COM CL A G4444C102 33,273 3,280,000 SH DFND 1 3,280,000 0 0
HORIZON THERAPEUTICS PUB L SHS G46188101 10,521 100,000 SH DFND 1 100,000 0 0
ICOSAVAX INC COM 45114M109 3,002 426,393 SH DFND 1 426,393 0 0
IGM BIOSCIENCES INC COM 449585108 10,751 402,200 SH DFND 1 402,200 0 0
IMMUNEERING CORP CLASS A COM 45254E107 14,898 2,302,626 SH DFND 1 2,302,626 0 0
IMV INC COM 44974L103 337 234,374 SH DFND 1 234,374 0 0
INTRA CELLULAR THERAPIES INC COM 46116X101 9,178 150,000 SH DFND 1 150,000 0 0
ITEOS THERAPEUTICS INC COM 46565G104 3,218 100,000 SH DFND 1 100,000 0 0
KARUNA THERAPEUTICS INC COM 48576A100 19,018 150,000 SH DFND 1 150,000 0 0
KEROS THERAPEUTICS INC COM 492327101 5,438 100,000 SH DFND 1 100,000 0 0
LONGBOARD PHARMACEUTICALS IN COM 54300N103 12,139 2,273,221 SH DFND 1 2,273,221 0 0
MEIRAGTX HLDGS PLC COM G59665102 2,078 150,000 SH DFND 1 150,000 0 0
MIRATI THERAPEUTICS INC COM 60468T105 4,111 50,000 SH DFND 1 50,000 0 0
MONTE ROSA THERAPEUTICS INC COM 61225M102 42,091 3,002,199 SH DFND 1 3,002,199 0 0
OLEMA PHARMACEUTICALS INC COM 68062P106 8,869 2,082,000 SH DFND 1 2,082,000 0 0
ORCHARD THERAPEUTICS PLC ADS 68570P101 183 256,649 SH DFND 1 256,649 0 0
PHARVARIS N V COM N69605108 12,420 684,888 SH DFND 1 684,888 0 0
PLIANT THERAPEUTICS INC COM 729139105 3,382 482,413 SH DFND 1 482,413 0 0
PRAXIS PRECISION MEDICINES I COM 74006W108 7,682 752,406 SH DFND 1 752,406 0 0
PRECISION BIOSCIENCES INC COM 74019P108 1,067 346,524 SH DFND 1 346,524 0 0
PROMETHEUS BIOSCIENCES INC COM 74349U108 68,853 1,823,444 SH DFND 1 1,823,444 0 0
PYXIS ONCOLOGY INC COMMON STOCK 747324101 2,702 668,854 SH DFND 1 668,854 0 0
RAIN THERAPEUTICS INC COM 75082Q105 11,796 2,326,660 SH DFND 1 2,326,660 0 0
RENOVACOR INC COM 75989E106 2,120 500,000 SH DFND 1 500,000 0 0
REVOLUTION MEDICINES INC COM 76155X100 50,894 1,995,066 SH DFND 1 1,995,066 0 0
ROCKET PHARMACEUTICALS INC COM 77313F106 13,775 868,550 SH DFND 1 868,550 0 0
STOKE THERAPEUTICS INC COM 86150R107 22,898 1,087,807 SH DFND 1 1,087,807 0 0
TALARIS THERAPEUTICS INC COM 87410C104 11,559 1,174,723 SH DFND 1 1,174,723 0 0
TANGO THERAPEUTICS INC COM 87583X109 37,136 4,899,185 SH DFND 1 4,899,185 0 0
TARSUS PHARMACEUTICALS INC COM 87650L103 23,144 1,375,982 SH DFND 1 1,375,982 0 0
TURNING POINT THERAPEUTICS I COM 90041T108 99,345 3,700,000 SH DFND 1 3,700,000 0 0
TYRA BIOSCIENCES INC COM 90240B106 8,105 757,432 SH DFND 1 757,432 0 0
VECTIVBIO HLDG AG ORD SHS H9060V101 9,790 2,078,485 SH DFND 1 2,078,485 0 0
VENTYX BIOSCIENCES INC COM 92332V107 10,657 785,303 SH DFND 1 785,303 0 0
VERVE THERAPEUTICS INC COM 92539P101 15,990 700,710 SH DFND 1 700,710 0 0
VIGIL NEUROSCIENCE INC COM 92673K108 4,206 616,786 SH DFND 1 616,786 0 0
VIRIDIAN THERAPEUTICS INC COM 92790C104 18,490 1,000,000 SH DFND 1 1,000,000 0 0
X4 PHARMACEUTICALS INC COM 98420X103 182 103,980 SH DFND 1 103,980 0 0
Y-MABS THERAPEUTICS INC COM 984241109 1,782 150,000 SH DFND 1 150,000 0 0

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings